Du är här

2014-05-07

Bionor Pharma ASA: Invitation to Webcast of Bionor Pharma Q1 2014 Results 14 May

Bionor Pharma ASA (OSE:BIONOR) will announce its first quarter 2014 results 14
May 2014 at 7.00 CEST. The quarterly report and presentation will be
available at the Company's website at this timewww.bionorpharma.com.
Presentation of first quarter results by CEO Anker Lundemose and CFO Synne
Røine will be webcasted at 08.30.

Schedule for the webcast /teleconference 14 May
08.25 - Log in to the webcast-link, and/or use conference call numbers
08.30 - Review of results by Bionor Pharma CEO Anker Lundemose and CFO Synne
Røine

The webcast will be available athttp://www.mediaserver.com/m/p/m9qvw3wq
Conference Call numbers
Use the following numbers to participate in the Q&A session at the end of the
presentation or listen to the webcast by telephone:
Participants, Local - London, United Kingdom: +44(0)20 3427 1937
Participants, Local - NY, USA: +1646 254 3372
Participants, Local - Oslo, Norway: +472100 6913
Participants, Local - Copenhagen, Denmark: +4532 71 16 63
Participants, Local - Stockholm, Sweden: +46(0)8 5065 3931

Confirmation Code: 6687308
Participants will have to quote the above code when dialling into the
conference.

One week replay - conference call replay numbers
Webcast is available for replay at the following numbers:
Local - Copenhagen, Denmark: 32 71 09 13
Local - London, United Kingdom: (0)20 3427 0598
Local - Local - NY, USA: 347 366 9565
Local - Oslo, Norway: 2100 0498
Local - Stockholm, Sweden: (0)8 5051 3897

Replay Pass code: 6687308

Bionor Pharma ASA
Synne Røine
CFO
Tel +47 99 22 98 92

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bionor Pharma ASA via Globenewswire

HUG#1783495

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.